ClinicalTrials.gg
CompletedNCT07103499COREBREATHUpdated Nov 3, 2026

Abdominal and Core Exercises on Respiratory Functions in Obese and Overweight Women (COREBREATH)

An interventional study of Pilates-Based Core and Breathing Exercise Program in Obesity, Overweight and Pulmonary Disease, sponsored by Ondokuz Mayıs University. Completed at 2 sites in Turkey (Türkiye). Open to female participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by Ondokuz Mayıs University · Not applicable, Interventional, and Treatment

How we know

Updated Nov 3, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Obesity by Ondokuz Mayıs University — 4 open to participants now, 4 under way, none of them phase 3. Obesity · Ondokuz Mayıs University.

Started
2025
with 1 other
No phase
7 of 10
2 open now
Registered
7th of 10
by date

Among the 10 studies in Obesity by Ondokuz Mayıs University, this one is one of 2 that started in 2025, is one of 7 with no phase, and was the 7th registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

4 of the 10 studies in Obesity by Ondokuz Mayıs University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years to 60 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Obesity by Ondokuz Mayıs University, or all of them as a file.
02

Study summary

This study aims to examine the effects of an 8-week Pilates-based exercise program on breathing functions in overweight and obese women (BMI ≥ 25). The program includes exercises for abdominal endurance and core stabilization, performed three times a week.

Participants will be divided into two groups: an exercise group and a control group. Before and after the program, measurements will include lung function (spirometry), breathing rate, breath-holding time, abdominal mobility, core endurance (curl-up test), and quality of life (SF-36 questionnaire).

The goal is to find out whether this type of exercise can improve breathing and overall health in women with excess weight.

Read the detailed description

This study aims to investigate the effect of an 8-week Pilates-based abdominal endurance and core stabilization exercise program on respiratory function in obese and overweight women (BMI ≥ 25). The intervention program is planned to last for a total of 24 sessions, 3 days a week. The exercises will be performed using reformer and cadillac devices, under the supervision of a physical therapist, at the Easyfiz Healthy Living Center.

Participants will be randomly assigned to two groups: an experimental group receiving the exercise intervention and a control group not receiving the intervention. Assessments conducted before and after the study for both groups will include the following parameters:

  • Spirometry (FEV₁, FVC, FEV₁/FVC ratio),
  • Respiratory rate,
  • Breath-holding time (in seconds),
  • Thoracoabdominal expansion (measured with a tape measure at the epigastric, subcostal, and lower costal levels),
  • Core muscle endurance (using the ACSM Curl-Up test),
  • Quality of life (using the 36-item Short Form - SF-36).

The exercise program will be planned in three phases:

Weeks 1-2: beginner level, Weeks 3-5: intermediate level, Weeks 6-8: advanced level. Each session will last approximately 45-50 minutes and will consist of a warm-up (diaphragmatic breathing and mobilization), main exercise (core stability and breathing-focused movements), and cool-down (stretching and breathing relaxation exercises).

This study aims to contribute to the field of cardiopulmonary rehabilitation by demonstrating the effects of a comprehensive exercise approach aimed at improving respiratory function and quality of life in obese individuals.

03

Conditions studied

  • Obesity
  • Overweight
  • Pulmonary Disease
  • Muscle Weakness

Keywords

  • Obesity
  • Overweight
  • Pulmonary Function
  • Pilates
  • Core Stabilization
  • Abdominal Endurance
  • Breathing Exercises
  • Body Mass Index
  • Respiratory Rate
04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Eligibility criteria

inclusion criteria

  1. Women aged 18-60
  2. (BMI) ≥ 25 kg/m² (obese and overweight)
  3. Baseline FEV0 value ≥ 80% (measured by spirometry)
  4. Individuals without respiratory disease (no diagnosis of asthma, , etc.)
  5. Individuals who have not engaged in regular exercise in the past 6 months
  6. Individuals without orthopedic or neurological conditions that physically prevent participation in the exercise protocol
  7. Non-pregnant individuals
  8. Individuals who voluntarily agree to participate in the study and sign the form exclusion criteria

1. Individuals with a FEV0 value \<80% (due to risk of obstructive lung disease) 2. Individuals who have undergone surgery in the abdomen, waist, or pelvic area within the last 6 months 3. Individuals with orthopedic, neurological, or systemic diseases that would prevent them from exercising 4. Individuals who have been engaging in regular exercise for 3 or more days per week in the past 3 months 5. Individuals with diagnosed respiratory diseases (e.g., asthma, COPD, etc.) 6. Individuals who are unable to comply with the exercise program due to psychiatric diagnosis or communication difficulties

Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
54 participants (actual)

Study arms

  • Experimental
    Intervention Group

    This group will participate in an 8-week supervised Pilates-based exercise program focused on core stabilization and abdominal endurance. Sessions will be held three times a week at Easyfiz Clinic using reformer and cadillac Pilates equipment. Each session will include diaphragmatic breathing-based warm-up and cool-down components.

    Behavioral: Pilates-Based Core and Breathing Exercise Program

  • No intervention
    Control Group

    Participants in this group will not receive any specific exercise or breathing intervention. They will be instructed to maintain their usual daily activities during the study period.

Interventions

  • BehavioralPilates-Based Core and Breathing Exercise Program

    An 8-week supervised Pilates-based exercise program for overweight and obese women, focusing on abdominal endurance and core stabilization. Sessions (3/week) include diaphragmatic breathing, use of reformer and cadillac equipment, and structured warm-up, main, and cool-down phases.

06

What researchers measure

Primary outcomes

  1. Forced Vital Capacity (FVC) - Spirometry

    Forced vital capacity (FVC) was assessed using spirometry and expressed in liters (L). FVC represents the maximum volume of air that can be forcibly exhaled after a maximal inspiration.

    Time frame: Baseline and immediately after the 8-week intervention

  2. Forced Expiratory Volume in 1 Second (FEV₁) - Spirometry

    Forced expiratory volume in one second (FEV₁) was assessed using spirometry and expressed in liters (L). FEV₁ represents the volume of air forcibly exhaled during the first second of a forced expiratory maneuver following maximal inspiration.

    Time frame: Baseline and immediately after the 8-week intervention

  3. FEV₁/FVC Ratio - Spirometry

    The FEV₁/FVC ratio was calculated from spirometric measurements as the ratio of forced expiratory volume in one second (FEV₁) to forced vital capacity (FVC) and expressed as a percentage (%)

    Time frame: Baseline and immediately after the 8-week intervention

  4. Peak Expiratory Flow Rate (PEFR) - Spirometry

    Peak expiratory flow rate (PEFR) was assessed using spirometry and expressed in liters per second (L/s). PEFR represents the maximum expiratory flow achieved during a forced expiratory maneuver following maximal inspiration.

    Time frame: Baseline and immediately after the 8-week intervention

  5. Upper Thoracic Expansion (Upper Chest Mobility)

    Upper thoracic expansion (upper chest mobility) was assessed using a tape measure and expressed in centimeters (cm). The difference in chest circumference between maximal inspiration and maximal expiration was recorded to evaluate upper thoracic mobility.

    Time frame: Baseline and immediately after the 8-week intervention

07

Study locations

2 sites
  • Ondokuz Mayıs Üniversitesi
    Samsun, Atakum 55270, Turkey (Türkiye)
  • Fizyoterapist Reyhan Arzum Apraş Özel Sağlık Meslek Hizmet Birimi
    Çorum, Merkez 19200, Turkey (Türkiye)
08

References and documents

Publications

  • Souza C, Kruger RL, Schmit EFD, Wagner Neto ES, Reischak-Oliveira A, de Sa CKC, Loss JF. Cardiorespiratory Adaptation to Pilates Training. Res Q Exerc Sport. 2021 Sep;92(3):453-459. doi: 10.1080/02701367.2020.1749222. Epub 2020 Jun 4. PubMed 32493165 ↗
  • Afsari, Z., Rahimi, N. M., & Azimkhani, A. (2024). Investigating the Effects of Dynamic Neuromuscular Stabilization Exercises on Chest Mobility, Upright Sitting Height, and Quality of Life in Obese Women. Physical Treatments-Specific Physical Therapy Journal, 14(2), 137-146.

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared with other researchers.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2025 to primary completion in Oct 2025, 2 months.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 2 months is below that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 3, 2026: start Jun 2025 → Aug 2025, primary completion Sep 2025 → Oct 2025 and completion Sep 2025 → Oct 2025.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 29, 2025
First posted
Aug 5, 2025
StartActual
Aug 1, 2025was Jun 2025
Primary completionActual
Oct 1, 2025was Sep 2025
CompletionActual
Oct 1, 2025was Sep 2025
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Jun 15, 2025→Aug 1, 2025
Nov 3, 2026
Primary completion
Sep 15, 2025→Oct 1, 2025
Nov 3, 2026
Study completion
Sep 15, 2025→Oct 1, 2025
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    Start date Jun 15, 2025→Aug 1, 2025
    Primary completion Sep 15, 2025→Oct 1, 2025
    Study completion Sep 15, 2025→Oct 1, 2025
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07103499
Responsible party
MİNE PEKESEN KURTÇA (Ass.Prof., Ondokuz Mayıs University) — Principal investigator
First posted
Aug 5, 2025
Start date
Aug 1, 2025
Primary completion
Oct 1, 2025
Completion
Oct 1, 2025
Last update
Nov 3, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion